Abstract Details

Title COVID19 Neurological Manifestations in the Veteran’s Community

Topic General Neurology

Presentation(s) General Neurology Posters (7:00 AM-5:00 PM)

Poster/Presentation
Number 048

Objective The nervous system is not spared by COVID19 and can get involved during the disease course regardless of the respiratory status. We studied the neurological manifestations of COVID19 in patients who were diagnosed at the Audie L Murphy Veteran's Affair (VA) hospital in San Antonio, Texas.

Background Increasing reports of COVID19 related neurological complications such as headache, anosmia, neuropathy, stroke, and seizure are being released every day. Although the exact pathophysiology of Coronavirus transmission to the nervous system is still unknown, research shows that the virus invades the nerve endings anterograde or retrogradely. The largest retrospective study was done in Wuhan, China in which 36.4% of their 214 patients with COVID 19 had neurological complications. In this research, we reviewed the prevalence of neurological symptoms amongst the veteran’s population.

Design/Methods Veterans with confirmed COVID19 polymerase chain reaction (PCR) are enrolled in the Neurology Convalescence Program at least 30 days after the resolution of the acute infection. Patients are contacted over the phone and a detailed neurological review of system is performed. Available medical records, laboratory results, and imaging are reviewed.

Results A total of 41 patients are included in this preliminary analysis. Their mean age is 53.73 and 78% are men (n:32). The most common neurological disorders are headache (n:20, 48.7%) followed by anosmia (n:17, 41.4%), memory or concentration issues (n:14, 34.1%), dysgeusia (n:13, 31.7%), dizziness (n:8 ,19.5%) and sensory changes (n:6, 14.6%).

Conclusions COVID19 neurological complications are still being explored longterm recovery is unknown. Our study suggests that some neurological conditions such as headache can occur at a higher rate amongst veterans. Additional data of this ongoing study will be available at the time of the AAN meeting.

Authors/Disclosures
Leila Saadatpour, MD PRESENTER	Dr. Saadatpour has nothing to disclose.
Cassie N. Chan, MD (Penn State Milton S. Hershey Medical Center)	Dr. Chan has nothing to disclose.
Aaisha Mozumder, MD	Dr. Mozumder has nothing to disclose.
Alejandro Tobon, MD, FAAN (South Texas Veterans Health Care System)	Dr. Tobon has nothing to disclose.

��ɫ��

��ɫ��